Therefore, CM reduced the production of TNFα, a cytokine with a central role in inflammation and tissue injury which has become an important target for the development of effective therapeutic agents in rheumatoid arthritis and other chronic inflammatory conditions (Beutler, 1999). The gene discussed is TNF; the disease is rheumatoid arthritis.